allylamine has been researched along with Hyperglycemia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Esan, O; Viljoen, A; Wierzbicki, AS | 1 |
Ishisaka, DY; Jukes, T; Leahy, A; Qian, C; Romanelli, RJ; Ye, X | 1 |
Goldfine, AB | 1 |
Marrs, JC | 1 |
Bailey, CJ; Barnett, AH; Del Prato, S; Tahrani, AA | 1 |
Dunn, FL; Grundy, SM; Vega, GL | 1 |
3 review(s) available for allylamine and Hyperglycemia
Article | Year |
---|---|
Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway.
Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Risk Factors | 2008 |
Colesevelam for the management of type 2 diabetes.
Topics: Allylamine; Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Cholesterol; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Humans; Hyperglycemia | 2009 |
Management of type 2 diabetes: new and future developments in treatment.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Allylamine; Anticholesteremic Agents; Bariatric Surgery; Bile Acids and Salts; Cardiovascular System; Colesevelam Hydrochloride; Comorbidity; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glucokinase; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Resistance; Insulin-Secreting Cells; Liver; Obesity; Peptides; Randomized Controlled Trials as Topic; Receptors, Dopamine D2; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Venoms | 2011 |
2 trial(s) available for allylamine and Hyperglycemia
Article | Year |
---|---|
Colesevelam in the treatment of hypercholesterolemia and hyperglycemia: a retrospective analysis from an ambulatory care medical network.
Topics: Adolescent; Adult; Aged; Allylamine; Ambulatory Care; Anticholesteremic Agents; California; Cholesterol, LDL; Colesevelam Hydrochloride; Female; Humans; Hypercholesterolemia; Hyperglycemia; Male; Middle Aged; Retrospective Studies | 2013 |
Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome.
Topics: Adult; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Colesevelam Hydrochloride; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome | 2011 |
1 other study(ies) available for allylamine and Hyperglycemia
Article | Year |
---|---|
Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia.
Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperglycemia; Hyperlipidemias; Hypolipidemic Agents; Triglycerides | 2022 |